Nomura Holdings
CRL icon

Nomura Holdings’s Charles River Laboratories CRL Stock Holding History

Nomura Holdings’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,100,000
Closed -$167M – 1905
2025
Q2 		$167M Buy
1,100,000
+500,000
+83% +$66.7M 0.35% 54
2025
Q1 		$90.3M Buy
+600,000
New +$101M 0.17% 92
2024
Q3 		– Sell
-12,500
Closed -$2.58M – 1607
2024
Q2 		$2.58M Buy
+12,500
New +$2.83M ﹤0.01% 863

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Nomura Holdings's CRL Position: Q2 2026 in Review

Nomura Holdings increased its Charles River Laboratories (CRL) stake by 1,806% in Q2 2026, buying an estimated $14.6M and bringing the position to 86,744 shares worth $19.7M. The position accounts for 0.02% of the portfolio, ranked #366.

Nomura Holdings first reported a position in CRL in Q2 2013 and has held it in 26 quarters since. The position peaked at $238M in Q2 2025. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Nomura Holdings held 86,744 shares of Charles River Laboratories worth $19.7M as of Q2 2026.
  • Nomura Holdings bought 82,194 Charles River Laboratories shares in Q2 2026, an estimated $14.6M.
  • Charles River Laboratories made up 0.02% of Nomura Holdings's portfolio in Q2 2026, its #366 holding.
  • Nomura Holdings first reported a position in Charles River Laboratories in Q2 2013 and has held it in 26 quarters since.
  • Nomura Holdings's Charles River Laboratories position peaked at $238M in Q2 2025.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.